ETH-LAD
From Wikipedia, the free encyclopedia
 |
|
|
ETH-LAD
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C21H27N3O |
| Mol. mass | 337.47 g/mol |
| Synonyms | ETH-LAD, 6-ethyl-6-nor-Lysergic acid diethylamide |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | hepatic |
| Half life | ? |
| Excretion | renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
ETH-LAD, 6-ethyl-6-nor-lysergic acid diethylamide is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. ETH-LAD is a hallucinogenic drug similar to LSD, and is slightly more potent than LSD itself with an active dose reported at between 40 and 150 micrograms. ETH-LAD has subtly different effects to LSD, described as less demanding.
ETH-LAD has been sold by some research chemical suppliers but might be considered illegal in some countries due to its structural similarity to LSD.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
AL-LAD, ALD-52, BU-LAD, CYP-LAD, Diallyllysergamide, DAM-57, Ergonovine, ETH-LAD, LAE-32, LSD, LPD-824, LSM-775, Methylergonovine, MLD-41, PARGY-LAD, PRO-LAD
